Scott Fung - Concepedia

Author

Scott Fung

University of Toronto ORCID

Also Known As

Carla S. Coffin, Curtis L Cooper, D Brainard, S Fung, S K Fung, S. Fung, S. K. Fung, SL Fung, Scott Fung, Scott K Fung

173

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

University of Toronto Toronto General Hospital Gilead Sciences (United States)University Health Network Chinese University of Hong Kong

About

Scott Fung is an author at University of Toronto specializing in medicine, hepatitis, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	35	3.5K
2	Health Sciences	4	4	156
3	Public Health	2	2	112
4	Engineering	1	1	62
5	Biomolecular Engineering	1	1	62

Scott Fung

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Intestinal microbiota in patients with nonalcoholic fatty liver disease Marialena Mouzaki, Elena M. Comelli, Bianca M. Arendt, Hepatology	2013	716
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial Henry Lik‐Yuen Chan, Scott Fung, Wai Kay Seto, The Lancet. Gastroenterology & hepatology HepatologyViral HepatitisHepatitis BHepatitisAntiviral Therapy	2016	447
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection Kosh Agarwal, Maurizia Rossana Brunetto, Wai Kay Seto, Journal of Hepatology HepatologyViral HepatitisPharmacologyHepatitis BHepatitis	2018	406
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease Marialena Mouzaki, Alice Y. Wang, Robert Bandsma, PLoS ONE	2016	378
Virologic response and resistance to adefovir in patients with chronic hepatitis B Scott Fung, Hee Bok Chae, Robert J. Fontana, Journal of Hepatology	2005	335
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids Bianca M. Arendt, Elena M. Comelli, David W.L., Hepatology	2015	331
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, Gastroenterology	2015	331
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients W. Ray Kim, Thomas Berg, Tarik Asselah, Journal of Hepatology HepatologyNon-invasive AssessmentViral HepatitisLiver PhysiologyHepatitis B	2015	284
Evolution of multi-drug resistant hepatitis B virus during sequential therapy Hyung Joon Yim, Munira Hussain, Ying Liu, Hepatology HepatologyViral HepatitisAntiviral TherapyPharmacologyHepatitis B	2006	253
Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B W. Ray Kim, Rohit Loomba, Thomas Berg, Cancer	2015	213

Page 1